- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/40 - Acylated on said nitrogen atom
Patent holdings for IPC class C07D 231/40
Total number of patents in this class: 433
10-year publication summary
|
24
|
45
|
26
|
25
|
26
|
20
|
18
|
22
|
29
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 2832 |
18 |
| Bayer Cropscience AG | 1885 |
14 |
| BASF SE | 21150 |
13 |
| The Regents of the University of California | 20574 |
11 |
| Array BioPharma Inc. | 458 |
11 |
| Dow AgroSciences LLC | 1196 |
8 |
| Novartis AG | 10327 |
7 |
| Boehringer Ingelheim International GmbH | 4509 |
7 |
| Shionogi & Co., Ltd. | 863 |
7 |
| F. Hoffmann-La Roche AG | 7837 |
6 |
| Araxes Pharma LLC | 91 |
6 |
| Theravance Biopharma R&D IP, LLC | 425 |
6 |
| Sanofi | 4243 |
6 |
| Corteva Agriscience LLC | 2643 |
6 |
| Indiana University Research and Technology Corporation | 785 |
5 |
| Medivir UK Ltd | 6 |
5 |
| Plexxikon Inc. | 147 |
5 |
| Aurigene Oncology Limited | 128 |
5 |
| Duke University | 3166 |
4 |
| Chaperone Therapeutics, Inc | 5 |
4 |
| Other owners | 279 |